We also found that OCN levels were elevated in patients with non‐AD neurodegenerative diseases, such as frontotemporal dementia (FTD) and multiple system atrophy (MSA), suggesting that OCN changes are not specific to AD. This evidence concerns the gene BGLAP and neurodegenerative disease.